Fund manager

Farallon Capital Management

Farallon Capital Management · Event-driven

Quarter ending 30 Jun 2026 · Filed 14 Aug 2026 · 82 positions · $16.9B reported

Event-driven and multi-strategy manager based in San Francisco. Added from a public list of the largest hedge fund managers.

Top holdings

Top 15 of 82 positions by reported value. Weight is each position's share of the 13F total. Source: SEC Form 13F-HR, quarter ending 30 Jun 2026, filed 14 Aug 2026.
CompanyWeightValue (13F)
Revolution Medicines Inc (RVMD)15.0%$2.5B
Electronic Arts Inc9.6%$1.6B
Bridgebio Pharma Inc (BBIO)4.7%$800.1M
Protagonist Therapeutics Inc (PTGX)4.6%$778.2M
Exelixis Inc (EXEL)4.3%$732.8M
Liquidia Corporation (LQDA)3.9%$666.9M
Amazon Com Inc (AMZN)3.7%$627.5M
Lantheus Hldgs Inc (LNTH)3.7%$619.4M
Natera Inc (NTRA)3.6%$602.2M
Unitedhealth Group Inc (UNH)3.1%$528.1M
Thermo Fisher Scientific Inc (TMO)3.1%$526.0M
Roivant Sciences Ltd3.0%$506.4M
Aon Plc2.7%$458.6M
Boston Scientific Corp (BSX)2.7%$449.0M
Broadcom Inc (AVGO)2.6%$435.1M

Source: Form 13F-HR filing on SEC EDGAR (accession 0000908834-26-000432), for the quarter ending 30 Jun 2026, filed 14 Aug 2026. A 13F lists long US-listed equity positions only, filed up to 45 days after quarter end, so it is a look back, not a live portfolio. Values are as reported in the filing.

Open the interactive profile: buys and sells, track record, mimic portfolio